Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuma Kato

Showing results (151-160 of 190) with videos related to

Pageof 19
Sort By:
Cancers|February 11, 2023
Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T CellsOsamu Sato, Takahiro Tsuchikawa, Takuma Kato, et al.
Japanese Journal of Clinical Oncology|December 26, 2025
Real-world efficacy of switching androgen receptor signaling inhibitor therapy following apalutamide discontinuation because of adverse events in advanced prostate cancer: a multicenter studyYoichiro Tohi, Takuma Kato, Kengo Fujiwara, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 25, 2025
Needlestick Injury During Urological Surgery: A 15-Year Review From a Multi-Institutional Study in the Chugoku-Shikoku Japan Urological ConsortiumYutaro Sasaki, Satoshi Katayama, Yoichiro Tohi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 20, 2022
Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS-JAPAN studyTakuma Kato, Akira Yokomizo, Ryuji Matsumoto, et al.
BJU International|April 14, 2025
Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatmentIvo I de Vos, Cristina Marenghi, Fabio Badenchini, et al.
World Journal of Urology|October 20, 2020
Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPANHiromi Hirama, Mikio Sugimoto, Nobuyuki Miyatake, et al.
International Journal of Clinical Oncology|December 6, 2022
Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS-JAPAN studyYoichiro Tohi, Ryou Ishikawa, Takuma Kato, et al.
Prostate Cancer and Prostatic Diseases|July 13, 2021
Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPANTakuma Kato, Hiromi Hirama, Koji Mitsuzuka, et al.
RSC Medicinal Chemistry|December 18, 2023
Impact of multiple H/D replacements on the physicochemical properties of flurbiprofenHiromasa Uchiyama, Kazuho Ban, Shiho Nozaki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 24, 2025
Impact of Age on Treatment Patterns and Outcomes in Patients With Non-Metastatic Castration-Resistant Prostate CancerHiroki Hagimoto, Shinichi Sakamoto, Kodai Sato, et al.
Pageof 19

Showing results (151-160 of 190) with videos related to

Sort By:
Pageof 19
Cancers|February 11, 2023
Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T CellsOsamu Sato, Takahiro Tsuchikawa, Takuma Kato, et al.
Japanese Journal of Clinical Oncology|December 26, 2025
Real-world efficacy of switching androgen receptor signaling inhibitor therapy following apalutamide discontinuation because of adverse events in advanced prostate cancer: a multicenter studyYoichiro Tohi, Takuma Kato, Kengo Fujiwara, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 25, 2025
Needlestick Injury During Urological Surgery: A 15-Year Review From a Multi-Institutional Study in the Chugoku-Shikoku Japan Urological ConsortiumYutaro Sasaki, Satoshi Katayama, Yoichiro Tohi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 20, 2022
Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS-JAPAN studyTakuma Kato, Akira Yokomizo, Ryuji Matsumoto, et al.
BJU International|April 14, 2025
Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatmentIvo I de Vos, Cristina Marenghi, Fabio Badenchini, et al.
World Journal of Urology|October 20, 2020
Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPANHiromi Hirama, Mikio Sugimoto, Nobuyuki Miyatake, et al.
International Journal of Clinical Oncology|December 6, 2022
Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS-JAPAN studyYoichiro Tohi, Ryou Ishikawa, Takuma Kato, et al.
Prostate Cancer and Prostatic Diseases|July 13, 2021
Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPANTakuma Kato, Hiromi Hirama, Koji Mitsuzuka, et al.
RSC Medicinal Chemistry|December 18, 2023
Impact of multiple H/D replacements on the physicochemical properties of flurbiprofenHiromasa Uchiyama, Kazuho Ban, Shiho Nozaki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 24, 2025
Impact of Age on Treatment Patterns and Outcomes in Patients With Non-Metastatic Castration-Resistant Prostate CancerHiroki Hagimoto, Shinichi Sakamoto, Kodai Sato, et al.
Pageof 19